Anne Roivainen
PhD, Professor of Preclinical Imaging and Drug Research
Turku PET Centre
University of Turku and Turku University Hospital

Education and degrees:

  • 2004, Adjunct Professor (Experimental Nuclear Medicine), University of Turku, Faculty of. Medicine, Turku, Finland
  • 1998, PhD (Medicine), University of Turku, Faculty of. Medicine, Turku, Finland
  • 1990, MSc (Biochemistry (major), Chemistry, Medicine), University of Kuopio, Faculty of Natural & Health Sciences, Kuopio, Finland
  • 1987, BSc (Biochemistry), University of Kuopio, Faculty of Natural & Health Sciences, Kuopio, Finland

Current position:

  • Professor of Preclinical Imaging and Drug Research, University of Turku, Turku PET Centre, 2011–2021
  • Coordinator, University of Turku, Turku Center for Disease Modeling, Animal Imaging Unit, 2007–present

Previous work experience:

  • Academy of Finland Research Fellow, Turku PET Centre, 2007–2012
  • Academy of Finland Postdoctoral Researcher, Turku PET Centre, 2004–2006
  • Finnish Cancer Institute Postdoctoral Researcher, Turku PET Centre, 2002–2003
  • Postdoctoral Researcher/Biochemist, Turku University Hospital, Turku PET Centre, 1998–2006
  • PhD Student/Researcher, University of Turku, Department of Medical Microbiology and Immunology, 1992–1998
  • Research Associate, Turku University Hospital, Department of Pathology, 1991
  • Full-time Teacher (Mathematics & Chemistry), Klassillinen Upper Secondary School, Kuopio, Finland, 1989–1990
  • Career breaks (3): Maternity leaves, 1993, 1995, 2005.

Research funding  – Received grants during last 10 years (~3 M€)

  • Academy of Finland
  • Jane and Aatos Erkko Foundation
  • Business Finland
  • Sigrid Jusélius Foundation
  • State Research Funding (ERVA)
  • Finnish Foundation for Cardiovascular Research

(Co-)Supervisor of completed doctoral students (10)

  • Iina Laitinen, PhD 2009, “Imaging of the vulnerable atherosclerotic plaque. pre-clinical evaluation of PET tracers for vascular inflammation”; co-supervisor Juhani Knuuti
  • Tiina Ujula, PhD 2011, “Studies on 68Ga-based agents for PET imaging of cancer and inflammation”; co-supervisor Pirkko Härkönen.
  • Anu Autio, PhD 2012,”In vivo imaging of vascular adhesion protein 1 – preclinical studies with positron emission tomography”; co-supervisor Sirpa Jalkanen
  • Johanna Silvola, PhD 2012, “Detection of the vulnerable atherosclerotic plaque. pre-clinical evaluation of novel PET imaging probes with experimental models”; co-supervisor Juhani Knuuti.
  • Miikka Tarkia, PhD 2015, “Translational models of coronary artery disease, myocardial infarction and heart failure. Development, validation and in vivo imaging studies using positron emission tomography”; co-supervisor Antti Saraste.
  • Sanna Hellberg, PhD 2017, “Evaluation of macrophage-targeting PET tracers for imaging inflammation in atherosclerosis”; co-supervisor Antti Saraste.
  • Aida Kiviniemi, PhD 2017, “Molecular imaging-guided gene therapy of malignant gliomas”; co-supervisor Heikki Minn.
  • Helena Virtanen, PhD, 2017, “Vascular adhesion protein-1 as in vivo target for imaging of leukocyte transendothelial migration in inflammation”; co-supervisor Sirpa Jalkanen.
  • Max Kiugel, PhD 2018, “Molecular imaging of tissue repair after myocardial infarction: Preclinical evaluation of novel (68)Ga-labeled PET tracers”; co-supervisor Antti Saraste.
  • Meeri Käkelä, PhD 2020, “Gallium-68 radiolabeling of biomolecules for positron emission tomography with special reference to imaging of inflammation and bone”;  co-supervisor Xiang-Guo Li.
  • Maria Grönman, PhD 2020, ”PET imaging of ischaemic myocardial injury and angiogenesis”; co-supervisor Antti Saraste.
  • Petri Elo, PhD 2020, “Preclinical evaluation of novel radiopharmaceuticals for positron emission tomography imaging of animal models of multiple sclerosis”; co-supervisors Sirpa Jalkanen and Laura Airas.
  • Mia Ståhle, PhD 2020, “Molecular imaging and immunotherapy in atherosclerotic cardiovascular disease”; co-supervisor Antti Saraste.
  • Riikka Viitanen, PhD 2021, “Evaluation of 68Ga-labeled PET radiopharmaceuticals for imaging of αvβ3 integrin and vascular adhesion protein-1 in inflammation and cancer”; co-supervisor Sirpa Jalkanen.

Currently co-supervising the following doctoral students (11):

  • Jussi Mäkilä, MSc, “PET imaging of bone related miRNA”; co-supervisor Tiina Laitala-Leinonen.
  • Sauli Uotila, MD, “Molecular imaging of cardiovascular diseases”; co-supervisor Antti Saraste.
  • Jenni Virta, MSc, “Molecular imaging of cardiovascular disease in type-2 diabetes: Evaluation of experimental models and their responses to treatment”; co-supervisor Antti Saraste.
  • Olli Moisio, MSc, “Development of radiopharmaceuticals for PET imaging of inflammation and cancer”; co-supervisor Xiang-Guo Li.
  • Ella Kyläinpää, MSc, “Determining effects of diet, microbiological status and microbiota on the metabolic phenotype of ApoE-/- mice as a model for drug development”; co-supervisors Emrah Yatkin, Antti Saraste.
  • Arghavan Jahandideh, MSc, “Molecular imaging of cardiac inflammation using new PET tracers in experimental models”; co-supervisor Antti Saraste.
  • Maxwell Miner, MSc, “Radiosynthesis of [18F](2S, 4R)4-Fluoroglutamine for in-vivo PET imaging”;  co-supervisor Xiang-Guo Li.
  • Putri Andriana, MSc, “Development of PET imaging agent targeting macrophage mannose receptor in cardiovascular disease and cancer”;  co-supervisors Antti Saraste, Xiang-Guo Li.
  • Imran Iqbal, MSc, “Molecular imaging in myocardial infarction”; co-supervisor Antti Saraste.
  • Erika Atencio Herre, MSc, “Preclinical evaluation of new macrophage and fibrosis targeted imaging agents in experimental cardiovascular disease models”, co-supervisors Antti Saraste, Xiang-Guo Li

Member of Editorial Boards:

  • American Journal of Nuclear Medicine and Molecular Imaging
  • Contrast Media & Molecular Imaging
  • Molecules